Navigation Links
Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
Date:11/25/2007

Seek-Find-Act-Follow: Innovations Span Entire Breast Care Continuum, from Early Detection and Diagnosis, to Targeted Therapy, Monitoring and After

Care

CHICAGO, Nov. 25 /PRNewswire-FirstCall/ -- Siemens Medical Solutions (http://www.usa.siemens.com/medical) introduces the latest innovations to its breast care portfolio, designed to help detect, diagnose and treat breast cancer earlier, faster, and with greater precision, at the 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 25 to 30 at McCormick Place (Booth #7713, Hall B). As the world's first full-service diagnostics company, Siemens is showcasing its unique capabilities to provide solutions that address each step of breast care.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

"Siemens continues to raise the bar for innovation by offering a comprehensive range of breast care solutions, as evidenced by the leading-edge technologies on display at this year's RSNA," said Erich R. Reinhardt, Ph.D., member of the Managing Board of Siemens AG and president and CEO of Siemens Medical Solutions. "Siemens is enabling facilities to provide quality care tailored to the individual patient's needs and optimize productivity, workflow, and, ultimately, financial performance."

By combining advanced imaging, laboratory diagnostics, and information technologies, Siemens helps physicians not only detect, diagnose and treat breast cancer in its earliest, most treatable stages, but also provides them with comprehensive after-care solutions. This holistic approach enables shorter exams, streamlined workflow, and improved patient outcomes. With the movement toward a multimodality approach to breast care, imaging technologies such as ultrasound a
'/>"/>

SOURCE Siemens Medical Solutions
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
6. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
7. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
8. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
10. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
11. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... April 16, 2015 Vanda Pharmaceuticals Inc. (Vanda) ... the development and commercialization of products for the treatment ... release results for the first quarter of 2015 on ... The Company will host a conference call ... during which Vanda management will discuss the first quarter ...
(Date:4/16/2015)... April 16, 2015  Hologic, Inc. (NASDAQ: ... screening study i published on-line this week ... of the American Cancer Society. The ... of Pittsburgh Medical Center, supports current consensus guidelines ii ... women 30-65 years of age be co-tested with ...
(Date:4/16/2015)... April 16, 2015 Mallinckrodt plc (NYSE: ... today announced that it has completed its acquisition ... approximately $2.3 billion. The Ikaria acquisition extends Mallinckrodt,s ... reach into neonatal critical care with INOMAX ® ... for a highly vulnerable patient population. It also ...
Breaking Medicine Technology:Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4Mallinckrodt Completes Acquisition Of Ikaria 2Mallinckrodt Completes Acquisition Of Ikaria 3Mallinckrodt Completes Acquisition Of Ikaria 4Mallinckrodt Completes Acquisition Of Ikaria 5
... 2007 - Pro-Pharmaceuticals,Inc. (Amex: PRW), a developer ... Eliezer Zomer, Ph.D., Executive Vice,President, Product Development ... Advanced Solid Tumors of,5-FU with an Admixture ... of Oncodevelopmental Biology and Medicine,(ISOBM) Conference to ...
... Investigative Dermatology, FREEPORT, N.Y., May 16, 2007 ... clinical data that indicates,that OCTN-1 skin cells ... L-ergothioneine (EGT) as a protector against oxidative,damage, ... more powerful and,efficient antioxidant than idebenone, scavenging ...
Cached Medicine Technology:Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 2Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 3Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 4Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 5AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin,Cells Have the Ability to Recognize, Transport and Utilize,L-ergothioneine (EGT) As A Protector Against Oxidative Damage 2
(Date:4/17/2015)... 18, 2015 Rosetta Radiology is proud ... out their list of diagnostic imaging services. This solidifies ... on the Upper East Side of Manhattan. , The ... capacity. The addition of PET-CT, combined with Rosetta’s state ... ability to work with patients through several stages of ...
(Date:4/17/2015)... 17, 2015 Riviera Magazine ... Sadati of the Gallery of Cosmetic Surgery in ... beauty experts. The publication focused on his expertise ... cell fat grafting, eyelid surgery, laser resurfacing and rhinoplasty. ... surgery has resulted in thousands of satisfied patients ...
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital ... Carrollwood were all selected as Top Workplaces in Tampa ... County, is ranked number one for large businesses according ... conducted in partnership with an independent research firm. Florida ... that opened in October of 2012 with a vision ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 From the day ... ago, the Texas non-profit organization has empowered young people to ... effort to bring fresh water and the Gospel to ... Liberty University. Between March 17 and 27, students, faculty and ... 7,000 Liberians with fresh water and the Good News of ...
(Date:4/17/2015)... April 17, 2015 Consumers who prefer ... without modifications can now use the Insurance Pros USA ... insurance policy rates that are featured by leading companies ... plans that are offered are mixed between three of ... to 79. There are now term, universal and whole ...
Breaking Medicine News(10 mins):Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2
... Agreement Provides for Provider Services, Inc. to fund $600,000 for Product, ... Millennium pursuant to the terms of the $20,000,000 5-year Purchase ... ... N.J., Jan. 16 Millennium Biotechnologies,Inc., wholly owned subsidiary of Millennium ...
... 16 STERIS Corporation,(NYSE: STE ) today ... third,quarter earnings release before the market opens on ... 10:00 a.m. Eastern time. The conference,call can be ... or via phone,by dialing 1-888-392-9976 in the ...
... OMI Medical Imaging, Inc. (OMI),announced today that it ... the U.S. Bankruptcy Court for the Southern District of,Florida ... Act reimbursement cuts took effect on,January 1, 2007, the ... its secured lenders., OMI operates 21 free standing ...
... could show who will respond best to interferon beta ... differences might explain why some multiple sclerosis (MS) patients ... study. , Starting with 206 southern European patients with ... the researchers compared the DNA of patients whose symptoms ...
... at LSU Health Sciences Center New Orleans has been ... the William J. Gies Award for Outstanding Innovation. The ... a black-tie celebration on March 29, 2008 in conjunction ... Session at the Hilton Anatole in Dallas, Texas. Named ...
... CINCINNATI Human evolution has created enhancements in key ... so-called guardian of the genome by creating additional ... to guard against DNA damage that could cause cancer ... of scientists led by Cincinnati Childrens Hospital Medical Center ...
Cached Medicine News:Health News:Millennium Enters Into $600,000 Product Development Agreement to Fund Product Development for the $20,000,000 Purchase Agreement with Provider Services, Inc. 2Health News:STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call 2Health News:STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call 3Health News:OMI Medical Imaging, Inc. and Affiliated Companies File Chapter 11 Reorganization 2Health News:DNA Analysis Could Help Customize Treatments for MS 2Health News:LSUHSC dental school to be awarded top national honor 2Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 2Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 3Health News:Evolution of human genome's 'guardian' gives people unique protections from DNA damage 4
Liquichek™ Ethanol/Ammonia Control is a liquid product used to monitor ethanol and ammonia test procedures in the clinical laboratory....
Lyphochek Assayed Chemistry Control requires no special diluent and has good reconstituted stability for enzymes and CO2. It is assayed for most major instruments and methodologies....
Lyphochek Benzo/TCA Control Set B is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and antidepressant drugs....
Lyphochek Endocrine Control is a human based product designed to monitor plasma catecholamine testing procedures by HPLC. The analytes are spiked at critical concentrations to cover the dynamic range...
Medicine Products: